UNIVERSITY OF STELLENBOSCH
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 21, 2017 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 90 Total Citation Count
- Oct 17, 1991 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9102955 Yeast expressing cellulases for simultaneous saccharification and fermentation using celluloseNov 23, 09Aug 11, 15[C12P, C12N]
7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteinsJul 05, 01Nov 17, 09[A61K, C07H, C12P]
7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereofJul 05, 02May 01, 07[C07H]
6274311 Method and nucleotide sequence for transforming microorganismsMay 28, 98Aug 14, 01[C07H, C12Q, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0323,822 Yeast Expressing Saccharolytic Enzymes for Consolidated Bioprocessing Using Starch and CelluloseAbandonedJun 03, 11Dec 05, 13[C12N]
2013/0230,888 Heterologous Expression of Fungal Cellobiohydrolase 2 Genes in YeastAbandonedJul 03, 12Sep 05, 13[C12N]
2012/0269,851 EXPRESSION CASSETTES ENDCODING HIV-1 SOUTH AFRICAN SUBTYPE C MODIFIED PROTEINSAbandonedFeb 17, 12Oct 25, 12[A61K, C12P, C12N, A61P]
2010/0316,698 POLYNUCLEOTIDES ENCODING ANTIGENIC HIV TYPE C POLYPEPTIDES, POLYPEPTIDES AND USES THEREOFAbandonedNov 17, 09Dec 16, 10[A61K, C07H, C12N]
2002/0081,684 Method and nucleotide sequence for transforming microorganismsAbandonedJun 28, 01Jun 27, 02[C07H, C12P, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.